In aged rats (>24 months old) and Tg2576 AD transgenic mice (5 months old), bryostatin both blocked the reduction of vascular PKCε, MnSOD, and VEGF and attenuated microvascular loss and memory defects (Millien et al., 2022). Here, PRKCE is linked to Alzheimer disease.